Yu‐Huei Huang

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

Peter Nash, Bruce Kirkham, Masato Okada et al. · The Lancet · 2017 · 405 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Early improvement in PANSS‐30, PANSS‐8, and PANSS‐6 scores predicts ultimate response and remission during acute treatment of schizophrenia

Chun-Hsien Lin, H. S. Lin, Shuwen Lin et al. · Acta Psychiatrica Scandinavica · 2017 · 101 citations

Medicine, Behavioral Sciences, Psychiatry +17

The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label

Yu‐Hsin Wang, Chun‐Bing Chen, Wichittra Tassaneeyakul et al. · Clinical Pharmacology & Therapeutics · 2018 · 98 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Efficacy and safety of Indigo naturalis extract in oil (Lindioil) in treating nail psoriasis: A randomized, observer-blind, vehicle-controlled trial

Yin‐Ku Lin, Lai‐Chu See, Yu‐Huei Huang et al. · Phytomedicine · 2014 · 81 citations

Medicine, Dermatology, Pharmacology +7

Comparison of indirubin concentrations in indigo naturalis ointment for psoriasis treatment: a randomized, double‐blind, dosage‐controlled trial

Lai‐Chu See, Yu‐Huei Huang, Rosaline Chung‐Yee Hui · British Journal of Dermatology · 2017 · 70 citations

Medicine, Dermatology, Pharmacology +12